A study of referral bias in NMOSD and MOGAD cohorts.
Journal article
Leal Rato M. et al, (2024), Mult Scler Relat Disord, 85
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Journal article
Nasir M. et al, (2024), Mult Scler Relat Disord, 85
PROMISE of low-cost immunosuppressants for myasthenia gravis.
Journal article
Ramdas S. and Palace J., (2024), Lancet Neurol, 23, 223 - 225
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis.
Journal article
Cagol A. et al, (2023), JAMA Neurol
Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course.
Journal article
Abdel-Mannan O. et al, (2023), J Neurol Neurosurg Psychiatry
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.
Journal article
Pagnamenta AT. et al, (2023), Genome Med, 15
Double-negative neuromyelitis optica spectrum disorder.
Journal article
Wu Y. et al, (2023), Mult Scler, 29, 1353 - 1362
A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study.
Journal article
Li Z. et al, (2023), Lancet Reg Health West Pac, 38
The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD.
Journal article
Berhanu D. et al, (2023), Mult Scler
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
Journal article
Chen B. et al, (2023), Ann Neurol
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab.
Journal article
Paul F. et al, (2023), Neurol Neuroimmunol Neuroinflamm, 10
Care Recommendations for the Investigation and Management of Children With Skeletal Muscle Channelopathies.
Journal article
Matthews E. et al, (2023), Pediatr Neurol, 145, 102 - 111
The emerging spectrum of foetal acetylcholine receptor antibody-associated disorders (FARAD).
Journal article
Allen NM. et al, (2023), Brain
A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD).
Journal article
Leite MI. et al, (2023), Mult Scler Relat Disord, 75
Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG).
Journal article
Berrih-Aknin S. et al, (2023), BMJ Open, 13
Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients.
Journal article
Santoro JD. et al, (2023), Neurol Ther
It's not multiple sclerosis, what is it?!
Journal article
Huda S. and Palace J., (2023), Pract Neurol
Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients.
Journal article
Santoro JD. et al, (2023), Neurol Ther
Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
Journal article
Pittock SJ. et al, (2023), Ann Neurol
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.
Conference paper
Oertel FC. et al, (2023), J Neurol Neurosurg Psychiatry